Barclays
TELA icon

Barclays’s TELA Bio TELA Stock Holding History

Barclays’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$5 – 5534
2025
Q1 		$5 Buy
+4
New +$10 ﹤0.01% 5196
2024
Q3 		– Sell
-143
Closed -$672 – 5476
2024
Q2 		$672 Sell
143
-11,294
-99% -$59.5K ﹤0.01% 4701
2024
Q1 		$64.8K Sell
11,437
-10,833
-49% -$71.4K ﹤0.01% 4560
2023
Q4 		$147K Buy
22,270
+19,341
+660% +$112K ﹤0.01% 4533
2023
Q3 		$23.4K Sell
2,929
-246
-8% -$2.29K ﹤0.01% 4139
2023
Q2 		$32.2K Buy
+3,175
New +$32.5K ﹤0.01% 4014

Other funds holding TELA

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Barclays's TELA Position: Q2 2025 in Review

Barclays sold out of TELA Bio (TELA) in Q2 2025, closing a stake of 4 shares — an estimated $5 sold.

Barclays first reported a position in TELA in Q2 2023 and held it in 6 quarters. The position peaked at $147K in Q4 2023. 46 funds tracked by Wall St. Rank hold TELA as of Q2 2025.

  • Barclays reported no remaining TELA Bio position as of Q2 2025 after selling out during the quarter.
  • Barclays sold 4 TELA Bio shares in Q2 2025, an estimated $5.
  • Barclays first reported a position in TELA Bio in Q2 2023 and held it in 6 quarters.
  • Barclays's TELA Bio position peaked at $147K in Q4 2023.
  • 46 funds tracked by Wall St. Rank held TELA Bio as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.